Seattle Genetics reported $180.28M in Selling and Administration Expenses for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Abbvie ABBV:US $ 3.06B 110M
Acadia Pharmaceuticals ACAD:US $ 96.68M 9.23M
Agios Pharmaceuticals AGIO:US $ 31.51M 13K
Amgen AMGN:US $ 1.23B 197M
Astellas Pharma 4503:JP 142.42B 6.51B
Biomarin Pharmaceutical BMRN:US $ 194.62M 22.94M
Clovis Oncology CLVS:US $ 29.21M 4.13M
Daiichi Sankyo 4568:JP 104.74B 14.78B
Eisai 4523:JP 110.49B 9.03B
Esperion Therapeutics ESPR:US $ 30.38M 5.29M
Exelixis EXEL:US $ 102.86M 3.55M
Genmab GEN:DC 452M 60M
Glaxosmithkline GSK:US 2.68B 227M
Insmed INSM:US $ 56.75M 8.52M
Karyopharm Therapeutics KPTI:US $ 38.77M 4.21M
Merk MRK:US $ 2.3B 518M
Novartis NOVN:VX 3.5B 486M
Spectrum Pharmaceuticals SPPI:US $ 19.74M 849K
Takeda 4502:JP 223.43B 7.65B